febuxostat has been researched along with Sepsis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Du, YW; Li, XN; Liu, HB; Wang, TT; Wang, W | 1 |
| Bayoumi, A; Fadl, RR; Gayyed, MF; Ibrahim, S; Ibrahim, YF; Refaie, M | 1 |
| Damarla, M; Damico, RL; Gao, L; Hassoun, PM; Johnston, LF; Kim, BS; Kolb, TM; Liu, G; Varela, L; Wang, L | 1 |
3 other study(ies) available for febuxostat and Sepsis
| Article | Year |
|---|---|
Inhibition of Xanthine Oxidase Protects against Sepsis-Induced Acute Kidney Injury by Ameliorating Renal Hypoxia.
Topics: Acute Kidney Injury; Animals; Febuxostat; Hypoxia; Inflammation; Ischemia; Kidney; Lipopolysaccharides; Mice; Oxygen; Reactive Oxygen Species; RNA, Small Interfering; Sepsis; Xanthine Oxidase | 2022 |
Protective effect of febuxostat in sepsis-induced liver and kidney injuries after cecal ligation and puncture with the impact of xanthine oxidase, interleukin 1
Topics: Acute Kidney Injury; Alanine Transaminase; Animals; Aspartate Aminotransferases; Cecum; Creatinine; Febuxostat; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Kidney; Ligation; Liver; Liver Diseases; Male; Protective Agents; Rats, Wistar; Sepsis; Urea; Xanthine Oxidase | 2020 |
XOR inhibition with febuxostat accelerates pulmonary endothelial barrier recovery and improves survival in lipopolysaccharide-induced murine sepsis.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Febuxostat; Lipopolysaccharides; Lung Injury; Male; Mice, Inbred C57BL; Sepsis; Survival Analysis; Xanthine Dehydrogenase | 2017 |